Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 30.50
+0.89 (3.01%)
Oct 9, 2026, 3:05 PM CST
SHE:000513 Market Cap
SHE:000513 has a market cap or net worth of 23.61 billion as of October 9, 2026. It is the 4,695th most valuable company in the world and the 735th biggest in China. Its market cap has decreased by 26.55% in one year.
Market Cap
23.61B
Enterprise Value
19.99B
Revenue
10.75B
Global Rank
Country Rank
#735 China
PE Ratio
16.19
ChartMarket Cap Chart
Since July 14, 1997, SHE:000513's market cap has increased from 392.67M to 23.61B, an increase of 5,912.05%. That is a compound annual growth rate of 15.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 23.61B | -15.54% |
| Dec 31, 2025 | 27.95B | -8.97% |
| Dec 31, 2024 | 30.70B | 8.53% |
| Dec 29, 2023 | 28.29B | 3.04% |
| Dec 30, 2022 | 27.46B | -15.01% |
| Dec 31, 2021 | 32.31B | -2.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shijiazhuang Yiling Pharmaceutical | 25.71B |
| Zhejiang Huahai Pharmaceutical | 24.81B |
| Hubei Jumpcan Pharmaceutical | 23.98B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.64B |
| Walvax Biotechnology | 22.52B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.19B |
| Hybio Pharmaceutical | 20.98B |
| Tasly Pharmaceutical Group | 20.93B |